Breaking News Instant updates and real-time market news.

JPM

JPMorgan

$95.86

-0.13 (-0.14%)

, NWSA

News Corp.

$13.68

0.14 (1.03%)

09:11
10/14/17
10/14
09:11
10/14/17
09:11

Week in review: How Trump's policies moved stocks

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump and his administration with this weekly recap compiled by The Fly: 1. TAX REFORM: Tax reform will drive growth that benefits everyone, and companies and Congress need to "set partisan interests aside to find a way to pass tax reform," JPMorgan's (JPM) CEO Jamie Dimon wrote on NBC News' Think earlier this week. The executive argued that tax reform is important because "strong businesses create jobs and higher wages," and "the real beneficiary of corporate tax reform" will be the American workers. 2. MEDIA SECTOR: Shares of News Corp. (NWSA), Comcast (CMCSA), CBS (CBS), New York Times (NYT) and Viacom (VIAB) were under pressure on Wednesday following a tweet by President Donald Trump saying: "With all of the Fake News coming out of NBC and the Networks, at what point is it appropriate to challenge their License? Bad for country!" The tweet followed an earlier one, which said, "Fake @NBCNews made up a story that I wanted a 'tenfold' increase in our U.S. nuclear arsenal. Pure fiction, made up to demean. NBC = CNN!" Later in the day, and in response to a reporter's question at the White House, Trump said it is "disgusting" that the press can write "whatever they want to write." He again rebutted NBC News' report that he sought a tenfold increase in the nation's nuclear arsenal. Trump added that media "makes up sources" and that "there are no sources." 3. FACEBOOK: Facebook (FB) COO Sheryl Sandberg is expected to meet with the U.S. House of Representatives Intelligence Committee leaders, according to a report by Reuters on Wednesday, citing people familiar with the matter. The committee is currently investigating Russian interference in the 2016 presidential election and was presented with over 3,000 political ads believed to be purchased by Russia on Facebook right around the election. Also on Wednesday, CNBC said the House Intelligence Committee intends to release Russia-linked advertisements that ran on Facebook during the 2016 U.S. presidential election. However, the committee will not likely make the ads public before a November 1 hearing that will include officials from Facebook, Twitter (TWTR), and Google (GOOG), the report addeda. At an Axios event on Thursday, Sandberg also said that Facebook owes the American people "not just an apology, but determination" for their role in enabling Russian interference during the election. The executive acknowledged that "things happened on our platform in this election that shouldn't have happened," according to Axios. Another report, this time by Reuters, stated that Facebook has started to overhaul its political advertisement process and may implement some changes before U.S. elections next year. 4. HEALTHCARE: Insurers and hospital operators were under pressure on Friday after President Trump announced plans to cut off subsidy payments to insurers selling Affordable Care Act Coverage, a decision which leaked out after he signed an executive order pushing for new regulations to support cheap, loosely regulated health plans. Centene (CNC) has been among the hardest hit on the news, though Morgan Stanley analyst Zack Sopcak said he views the weakness in Centene as particularly "exaggerated" and presents a buying opportunity. Other publicly traded companies in the space include Aetna (AET), Anthem (ANTM), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG), Community Health (CYH), HCA Healthcare (HCA), LifePoint (LPNT), Tenet (THC), and Universal Health (UHS). "Week in Review" is The Fly's weekly recap of its recurring series of "Trump Effect" exclusive stories.

JPM

JPMorgan

$95.86

-0.13 (-0.14%)

NWSA

News Corp.

$13.68

0.14 (1.03%)

CMCSA

Comcast

$36.01

0.06 (0.17%)

CMCSK

Comcast

$58.00

(0.00%)

CBS

CBS

$57.00

0.49 (0.87%)

VIAB

Viacom

$26.00

1.43 (5.82%)

NYT

New York Times

$19.15

(0.00%)

FB

Facebook

$173.74

1.19 (0.69%)

TWTR

Twitter

$18.63

0.18 (0.98%)

GOOG

Alphabet

$989.68

1.85 (0.19%)

GOOGL

Alphabet Class A

$1,007.87

2.22 (0.22%)

CNC

Centene

$90.56

-3.12 (-3.33%)

CI

Cigna

$186.15

-0.81 (-0.43%)

HNT

Health Net

$0.00

(0.00%)

HUM

Humana

$237.73

-3.71 (-1.54%)

MOH

Molina Healthcare

$61.28

-2.14 (-3.37%)

UNH

UnitedHealth

$192.52

-0.4 (-0.21%)

WCG

WellCare

$168.64

0.33 (0.20%)

CYH

Community Health

$5.77

-0.24 (-3.99%)

HCA

HCA Healthcare

$74.58

0.36 (0.49%)

LPNT

LifePoint

$55.00

0.3 (0.55%)

THC

Tenet

$13.15

-0.71 (-5.12%)

UHS

Universal Health

$105.55

-0.37 (-0.35%)

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 20

    Oct

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 26

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 05

    Nov

  • 06

    Nov

  • 08

    Nov

  • 29

    Nov

  • 27

    Feb

  • 13

    Apr

  • 13

    Jul

  • 12

    Oct

JPM JPMorgan
$95.86

-0.13 (-0.14%)

09/26/17
DBAB
09/26/17
DOWNGRADE
Target $136
DBAB
Hold
PNC Financial downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Matt O'Connor downgraded PNC Financial (PNC) to Hold as he seeks to lessen exposure to traditional banks. The analyst sees net interest income growth slowing and credit costs inching up as the Fed raises short rates and the yield curve flattens. He believes a number of positives are priced into PNC shares. O'Connor upped his price target for the stock to $136 from $130. The analyst continues to prefer banks with a "turnaround angle," like Goldman Sachs (GS) and Wells Fargo (WFC), and remains positive on capital markets businesses like Morgan Stanley (MS). O'Connor this morning also downgraded JPMorgan (JPM) to Hold.
09/26/17
09/26/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. JPMorgan (JPM) and PNC Financial (PNC) were downgraded to Hold from Buy at Deutsche Bank. 2. Aflac (AFL) downgraded to Sell from Neutral at Citi with analyst Suneet Kamath saying the company is at an inflection point as Aflac Japan is too large to show meaningful growth and Aflac U.S. is "too small to move the growth needle." 3. Cardtronics (CATM) downgraded to Market Perform from Outperform at William Blair with analyst Robert Napoli citing the changes in the Australian market. 4. Cheesecake Factory (CAKE), Shake Shack (SHAK), and Habit Restaurants (HABT) were downgraded to Neutral from Outperform at Wedbush. 5. Genocea (GNCA) downgraded to Hold from Buy at Stifel with analyst Stephen Willey saying his visibility and confidence "remains admittedly low" after the company shelved GEN-003 and said it will shift focus on immuno-oncology and the development of neoantigen cancer vaccines. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/26/17
DBAB
09/26/17
DOWNGRADE
Target $96
DBAB
Hold
JPMorgan downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Matt O'Connor downgraded JPMorgan to Hold as he seeks to lessen exposure to traditional banks. The analyst sees net interest income growth slowing and credit costs inching up as the Fed raises short rates and the yield curve flattens. He believes further meaningful outperformance of JPMorgan shares will be harder amid increased competition within investment banking and trading as well as slowing loan growth. The analyst raised his price target for the shares to $96 from $90. The bank closed yesterday down 71c to $94.12.
10/09/17
FBCO
10/09/17
NO CHANGE
Target $110
FBCO
Outperform
JPMorgan price target raised to $110 from $103 at Credit Suisse
Credit Suisse analyst Susan Roth Katzke raised her price target for JPMorgan to $110 from $103 on valuation. The analyst reiterates an Outperform rating on the shares.
NWSA News Corp.
$13.68

0.14 (1.03%)

11/08/16
LYON
11/08/16
DOWNGRADE
LYON
Outperform
News Corp. downgraded earlier to Outperform from Buy at CLSA
CLSA analyst Sacha Krien downgraded News Corp to Outperform saying print advertising declines remain a concern.
07/14/17
07/14/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Safety, Income and Growth (safe) initiated with a Buy at Ladenburg. 2. News Corp. (NWSA) initiated with a Buy at Rosenblatt. 3. Woodward (WWD) initiated with an Outperform at Oppenheimer. 4. CBL & Associates (CBL) coverage resumed with a Hold at Stifel. 5. Supernus (SUPN) initiated with a Neutral at Janney Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/14/17
RSBL
07/14/17
INITIATION
Target $17
RSBL
Buy
News Corp. initiated with a Buy at Rosenblatt
Rosenblatt analyst Alan Gould initiated News Corp with a Buy and a $17 price target saying he has increased confidence the company will report annual EBITDA growth. Digital Real Estate EBITDA is now growing quicker than News and Information Services is declining, the analyst wrote. Gould now sees EBITDA and operating income growth of 4% and 10% compounded rates, while revenues remain flat due to the mix shift towards digital real estate, which has higher margins.
CMCSA Comcast
$36.01

0.06 (0.17%)

09/12/17
09/12/17
UPGRADE

Buy
Comcast upgraded to Buy on valuation at MoffettNathanson
As previously reported, MoffettNathanson upgraded Comcast to Buy from Neutral with a $45 price target. Analyst Craig Moffett said Comcast shares cheap following management comments on Q3 subscriber loses and the resulting stock selloff is overdone.
09/12/17
09/12/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Comerica (CMA) upgraded to Overweight from Neutral at Piper Jaffray with analyst Brett Rabatin saying the bank's mid-quarter update is better than expected. 2. Alcoa (AA) upgraded to Buy from Hold at Deutsche Bank with analyst Jorge Beristain basing the upgrade on the firm's commodity team raising its 2018 aluminum price forecast by 12% to $2,072 per ton. 3. Kroger (KR) upgraded to Buy from Hold at Pivotal Research with analyst Ajay Jain saying continued weakness in investor sentiment following Kroger's latest results presents a near-term buying opportunity. 4. Comcast (CMCSA) upgraded to Buy from Neutral at MoffettNathanson with analyst Craig Moffett saying Comcast shares cheap following management comments on third quarter subscriber loses and the resulting stock selloff is overdone. 5. Inovalon (INOV) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Ricky Goldwasser saying that the company's presentation at the firm's healthcare conference provided a line of sight to organic earnings acceleration in the second half of the year. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/17
STFL
10/06/17
NO CHANGE
Target $200
STFL
Buy
Netflix 'still the best value' for consumers despite price hike, says Stifel
After Netflix (NFLX) disclosed it is raising subscription prices for the Standard and Premium tiers in the U.S., Stifel analyst Scott Devitt said he expects "similar round number increases" in a number of other markets, noting that the company has also confirmed increases for its top two U.K. plans. The analyst, who noted that Hulu's ad-free option and HBO Now (TWX) remain as expensive or more expensive than Netflix, said its streaming service is "still the best value on the consumer Internet." Devitt keeps a Buy rating and $200 price target on Netflix shares.
09/29/17
JPMS
09/29/17
NO CHANGE
JPMS
Expert sees positive settlements for TiVo, says JPMorgan
JP Morgan analyst Sterling Auty hosted Bloomberg Intelligence Litigation Analyst Matt Larson to discuss TiVo's (TIVO) ITC and District Court cases with Comcast (CMCSA, CMCSK) and Hulu. Larson said he believes settlement is the most likely outcome in both cases, which Auty sees as a positive for TiVo. A positive resolution could have "material upside" for TiVo's shares, as it bolsters the case for TiVo driving earnings to the $3 per share level, Auty added. JP Morgan kept an Overweight rating and $34 price target on TiVo shares.
CMCSK Comcast
$58.00

(0.00%)

04/24/17
OPCO
04/24/17
NO CHANGE
OPCO
Sprint, DISH the only assets for sale, says Oppenheimer
Oppenheimer analyst Timothy Horan noted that wireless companies will be allowed to discuss M&A, and says he sees Sprint (S) and possibly DISH (DISH) as the only assets for sale. The analyst believes the most likely outcome is for consolidation around the four major wireless providers, something along the lines of Charter (CHTR)/Sprint, T-Mobile (TMUS)/Comcast (CMCSA; CMCSK), Verizon (VZ)/DISH, with AT&T's (T) position "fairly solidified" with DirectTV/Time Warner (TWX). Further, Horan suspects Sprint will be sold first, most likely to Charter, although T-Mobile is a possibility and could be the controlling company/management and likely paying a premium for Sprint.
04/26/17
FBCO
04/26/17
NO CHANGE
Target $37
FBCO
Outperform
Hulu stake could be for sale this year, says Credit Suisse
Credit Suisse analyst Omar Sheikh notes that Comcast (CMCSA; CMCSK) will be free to sell its 30% stake in Hulu from the end of 2017. The analyst believes there is a $100B domestic revenue opportunity for targeted TV advertising long-term, which vertically integrated networks/distributors will be in a strong position to exploit. Therefore, Sheikh argues that it would make sense for 21st Century Fox (FOX; FOXA) to acquire Comcast's stake in Hulu, if it becomes available, subject to valuation and appropriate programming supply agreements. He reiterates an Outperform rating and $37 price target on 21st Century Fox's shares.
CBS CBS
$57.00

0.49 (0.87%)

09/15/17
JPMS
09/15/17
NO CHANGE
Target $75
JPMS
Overweight
CBS recent share weakness overdone, says JPMorgan
JPMorgan analyst Alexia Quadrani views the recent pullback in shares of CBS (CBS) as overdone. The stock has underperformed over the prior month, down 12% versus the S&P 500 Index up 1%, Quadrani tells investors in a research note titled "Weather Channel's Gain is NFL's Pain; CBS Weakness Overdone." The analyst attributes yesterday's selloff to NFL ratings for week one, which declined 12% year-over-year. It is unreasonable to draw conclusions from just one weekend of games, especially last weekend given the storms, the analyst argues. Further, Quadrani says CBS CEO Les Moonves' comment yesterday that Amazon (AMZN) would be interested in bidding for NFL rights when they come due early next decade is "hardly news." She keeps an Overweight rating on CBS with a $75 price target.
09/13/17
NEED
09/13/17
NO CHANGE
NEED
CBS Internet video channels could be worth $7.2B, says Needham
Needham analyst Laura Martin estimates that CBS' (CBS) Internet video services could generate $1.2B of revenue in 2020. She notes that Netflix's (NFLX) market cap is six times its revenue. If CBS' Internet video services are valued using that multiple, they would be worth $7.2B, or 30% of CBS' current market cap, according to the analyst. She keeps an $80 price target and a Buy rating on the shares.
09/05/17
WELS
09/05/17
UPGRADE
Target $116
WELS
Outperform
Disney upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Marci Ryvicker upgraded Disney (DIS) to Outperform and raised her price target for the shares to $116 from $109. The owner of ESPN and ABC closed Friday up 31c to $101.50. Concerns over potential dilution from the BAMTech stake and the streaming apps are "widely overdone," Ryvicker tells investors in a research note where she also downgraded Viacom (VIAB). She expects the TV ecosystem will soon undergo on an accelerated push into over-the-top. As such, investors may need to start increasing exposure to media companies with solid streaming strategies, such as CBS (CBS), 21st Century Fox (FOXA), and Disney, and lessen exposure to those that do not, such as Viacom and Scripps Networks (SNI)/Discovery Communications (DISCA), Ryvicker argues. The analyst likes the current entry point for Disney shares.
09/19/17
09/19/17
NO CHANGE

Cowen lowers price targets on media companies
Cowen analyst Doug Crentz cut his price targets for several media companies, as he believes that the margin pressure on TV networks will continue. The analyst believes that consensus estimates for TV broadcasters are too high, as he expects that the decline in the sector's EBITDA margin will more than double this year, driven by lower ad and affiliate revenue. He believes that two "deep-pocketed, low margin competitors -Netflix (NFLX) and Amazon (AMZN) - are the root of the problem. He cut his price target on Viacom (VIAB) to $31 from $41, on Discovery (DISCA) to $19 from $25, on Fox (FOXA) to $29 from $32, on CBS (CBS) to $69 from $70 and on Disney (DIS) to $94 from $95.
VIAB Viacom
$26.00

1.43 (5.82%)

10/13/17
MSCO
10/13/17
NO CHANGE
Target $38
MSCO
Overweight
Viacom could be pushed back above $30 by Charter pact, says Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne noted press reports suggesting a negotiation going on between Viacom (VIAB) and Charter (CHTR) on a carriage agreement renewal and he is now modeling a nearly 15% one-time decline in blended affiliate fee pricing across Charter's footprint in exchange for broad distribution. If Viacom's networks get continued carriage on Charter, even with reduced fees, this could drive Viacom shares back above $30, contends Swinburne. He lowered his price target on Viacom to $38 from $42, but keeps an Overweight rating on the stock, noting that in any case the Charter relationship overhang will likely be removed by month end.
10/12/17
10/12/17
DOWNGRADE
Target $105

Neutral
Disney downgraded to Neutral on increased pay-TV caution at Guggenheim
As previously reported, Guggenheim analyst Michael Morris downgraded Disney (DIS) to Neutral from Buy, citing his increased caution toward pay-TV trends and concern that expectations for the contribution from its content cycle are too high. While he is optimistic about the company's proposed direct-to-consumer streaming products, he expects the initial investment and long lead time into the launch to weigh on sentiment over the next 12 months, Morris tells investors. The analyst, who lowered his price target on Disney to $105 from $122, also downgraded Viacom (VIAB) and AMC Networks (AMCX) this morning.
10/12/17
GUGG
10/12/17
DOWNGRADE
Target $25
GUGG
Neutral
Guggenheim sees downward fee revisions, cuts Viacom to Neutral
Guggenheim analyst Michael Morris downgraded Viacom (VIAB) to Neutral from Buy and cut his price target for the shares to $25 from $37. The analyst has "increased caution" on the company's ability to meet investor expectations for affiliate and advertising revenue growth in the coming years. Viacom's networks are at risk of downward fee revisions or carriage loss as distributors seek to mitigate cost pressures, Morris tells investors in a research note. The analyst expects total revenue for the pay-TV ecosystem to come under pressure.
10/12/17
10/12/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Matthew Fassler saying shares have achieved in three months what he had expected in a year on an improvement in sentiment, but not on higher earnings estimates. 2. Monro (MNRO) downgraded to Hold from Buy at Jefferies with analyst Bret Jordan citing expectations the company's earnings growth will slow in 2018 as its focus shifts from acquisitions to improving store-level execution. 3. Diamond Offshore (DO) downgraded to Sell from Neutral at Citi with analyst Scott Gruber saying that if an upturn is forthcoming, Transocean should outperform given a "diminution" of concern toward its balance sheet and more new contract catalysts. 4. Cummins (CMI) downgraded to Neutral following dealer checks at Longbow with analyst Faheem Sabeiha citing a recent truck dealer survey that suggests initial 2018 sales growth is below current industry forecasts, partly due to driver shortage concerns. 5. Disney (DIS), AMC Networks (AMCX), and Viacom (VIA, VIAB) were downgraded to Neutral from Buy at Guggenheim. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
NYT New York Times
$19.15

(0.00%)

FB Facebook
$173.74

1.19 (0.69%)

10/11/17
FBCO
10/11/17
NO CHANGE
Target $235
FBCO
Outperform
Facebook price target raised to $235 from $190 at Credit Suisse
Credit Suisse analyst Stephen Ju raised his price target for Facebook to $235 from $190 ahead of Q3 results as he increases his mobile newsfeed estimates on the heels of positive advertiser checks. The analyst reiterates an Outperform rating on the shares.
10/11/17
PIPR
10/11/17
NO CHANGE
PIPR
Overweight
Piper teen survey shows 'clear challenges' for Facebook and Twitter
Piper Jaffray analyst Sam Kemp says his firm's bi-annual survey of over 6,000 teens shows "clear challenges" for both Facebook (FB) and Twitter (TWTR). The youngest of teens "are simply not adopting these platforms," Kemp tells investors in a research note. The survey indicated 82% and 81% of teens are using Snapchat (SNAP) and Facebook's Instagram, respectively, and that these platforms share 93% of their users with each other. Kemp believes this is positive for Instagram as it's "ad unit and advertiser adoption are well ahead of Snap." Instagram is faring well against Snapchat, the analyst contends. He points out that his firm's longitudinal cohort data shows engagement is not declining with older cohorts on Facebook. Kemp reiterates an Overweight rating on Facebook and a Neutral rating on Snap.
10/13/17
COWN
10/13/17
NO CHANGE
Target $28
COWN
Outperform
Match Group price target raised to $28 from $22 at Cowen
Cowen analyst John Blackledge raised his price target on Match (MTCH) to $28 from $22 to reflect its successful launch of Tinder Gold during the quarter, its integrated advertising with Facebook (FB), and its march to $1B in revenues. Blackledge reiterated his Outperform rating on Match Group shares.
10/13/17
WBLR
10/13/17
NO CHANGE
WBLR
GrubHub integrated into Facebook food ordering service, says William Blair
William Blair analyst Ralph Schackart says his preliminary research in two large markets, Chicago and New York, indicates GrubHub (GRUB) is integrated into Facebook's (FB) food ordering and delivery service. The analyst notes that various articles today highlight that GrubHub is not integrated into Facebook. GrubHub shares are well off their lows and are now up 9c to $52.23 in late morning trading.
TWTR Twitter
$18.63

0.18 (0.98%)

08/31/17
WEDB
08/31/17
INITIATION
Target $12
WEDB
Neutral
Wedbush cites Snap's 'hugely unprofitable' history in Neutral initiation report
Wedbush analyst Michael Pachter initiated Snap (SNAP) last night with a Neutral rating and $12 price target. The shares closed yesterday down 3c to $14.96. Decelerating growth trends, "fierce" competition for user mindshare and advertiser dollars, and a history of being "hugely unprofitable" justify being on the sidelines with respect to the shares, Pachter tells investors in a research note. He notes his $12 price target reflects a slight premium to Twitter's (TWTR) multiple, since Snap "appears to have a longer runway for continued growth," and a discount to Facebook's (FB) multiple, a company with "superior monetization and growth trends."
08/30/17
AGIS
08/30/17
NO CHANGE
AGIS
Aegis sees signs of start of advertising recession
After speaking with Bryan Wiener, the Executive Chairman of online and traditional advertising agency 360i, Aegis analyst Victor Anthony said that his commentary, along with earnings results from ad agencies Interpublic Group (IPG) and WPP (WPPGY), leave him of the opinion that an ad recession is underway. Wiener believes Google (GOOG), Facebook (FB) and Amazon (AMZN) will be relatively insulated given they will continue to take share, and Anthony said he would continue to buy Alphabet and Facebook shares. The analyst keeps a Hold rating on Snap (SNAP) and a Sell rating on Twitter (TWTR).
10/04/17
BERN
10/04/17
NO CHANGE
BERN
Ahold Delhaize, Kroger deal would make sense, says Bernstein
Bernstein analyst Bruno Monteyne notes that Bloomberg is reporting speculation on Twitter (TWTR) that Ahold Delhaize (ADRNY) has hired advisors to study a possible $32/share Kroger (KR) bid. The analyst believes a merger makes sense both strategically and financially, but deal structure seems off - merger of equals rather than bid - and timing a bit too fast.
GOOG Alphabet
$989.68

1.85 (0.19%)

10/10/17
JEFF
10/10/17
NO CHANGE
Target $1200
JEFF
Buy
Alphabet valuation still looks compelling, says Jefferies
Jefferies analyst Brent Thill says Google's (GOOGL) valuation, even with the stock up 25% year-to-date, still looks compelling. The company "has the right pieces in place to deliver meaningful 20+% upside," Thill tells investors in a research note titled "Google Picture Book: No Shortage of Value in These Search Results." He believes Google's initiatives, like Google Cloud and recently raised bets on hardware, could boost consensus estimates. The analyst keeps a Buy rating on the shares with a $1,200 price target.
10/09/17
BERN
10/09/17
NO CHANGE
BERN
Alphabet Waymo still has 'significant limitations,' says Bernstein
Commenting on a media report saying Alphabet's Waymo is preparing to launch "a commercial ride-sharing service powered by self-driving vehicles with no human 'safety' drivers as soon as this fall," Bernstein analyst Max Warburton says that any service will be" very limited and experimental." However, he notes that its launch may scare auto sector investors. The Waymo vehicles still have "significant limitations," he contends, adding that they are not about to disrupt the industry soon.
10/03/17
KEYB
10/03/17
NO CHANGE
KEYB
Overweight
YouTube TV 'significant strategic benefits' offset lack of profit, says KeyBanc
KeyBanc analyst Andy Hargreaves says that Google's brand, engineering prowess, and budget position YouTube TV to capture share of U.S. pay-TV subscribers. While YouTube TV is unlikely to be profitable on a stand-alone basis, the analyst believes it creates a substantial opportunity for Google to capture TV ad dollars, accelerate consumption of traditional YouTube content on televisions, and benefit Google's broader advertising efforts. The analyst reiterates an Overweight rating on the shares.
10/05/17
KEYB
10/05/17
NO CHANGE
KEYB
Overweight
Google AI focus in hardware has potential, modest impact, says KeyBanc
KeyBanc analyst Andy Hargreaves says Google showed off new Pixel smartphones, additions to its smart speaker line, a new laptop, and other accessories at its hardware launch event yesterday. The analyst notes that the hardware matches up well against competitors, and features a heavy focus on artificial intelligence and machine learning-based features. However, distribution of the Pixel 2 remains limited and incremental advancements in the other hardware lines do not appear material enough to drive a noticeable inflection in Google's Other Revenue, where hardware sales are recognized, he contends. Hargreaves sees potential in Google's hardware business, but much greater distribution is likely necessary to drive a meaningful inflection in the model. He reiterates an Overweight rating on the shares.
GOOGL Alphabet Class A
$1,007.87

2.22 (0.22%)

10/11/17
FBCO
10/11/17
NO CHANGE
Target $1350
FBCO
Outperform
Alphabet price target raised to $1350 from $1100 at Credit Suisse
Credit Suisse analyst Stephen Ju raised his price target for Class A shares of Alphabet to $1350 from $1100 ahead of Q3 results. The analyst says his conversations with advertisers suggest minimal search budget growth deceleration coupled with potentially accelerating spend on YouTube due to multiple factors. He reiterates an Outperform rating on the shares.
CNC Centene
$90.56

-3.12 (-3.33%)

10/13/17
LEER
10/13/17
NO CHANGE
LEER
Ending of ACA subsidies most negative for Centene, says Leerink
Leerink analyst Ana Gupte says the shutting off of the cost sharing subsidies on Affordable Care Act exchanges is most negative for Centene (CNC). The company is "highly profitable" on the exchanges at 15% of earnings, Gupte tells investors in a research note. Molina Healthcare (MOH) and Anthem (ANTM) are exposed on the top line but are losing money, the analyst adds. She notes that UnitedHealth (UNH), Humana (HUM) and Aetna (AET) have exited the exchanges while WellCare (WCG) has not been on them. Centene in premarket trading is down 6% to $88.00 while Molina is down 3% to $61.50.
10/13/17
MSCO
10/13/17
NO CHANGE
MSCO
Centene weakness a buying opportunity, says Morgan Stanley
10/02/17
BERN
10/02/17
NO CHANGE
BERN
Bernstein does not anticipate ACA fix/repeal before 2018 election
While noting the resignation of Health Secretary Tom Price, Bernstein analyst Lance Wilkes says he does not anticipate an Affordable Care act fix or ACA repeal before the 2018 election. The analyst expects tax reform will "suck the oxygen out of the room" until close to the election. A fix for 2019 is possible, but faces the headwind of the 2018 election campaign, he contends, adding that he believes CSR funding could be included in a trade for the upcoming budget and the Health Insurance Fee could be suspended as part of tax reform, but both are not highly likely at this point. Publicly traded companies in the space include Aetna (AET), Anthem (ANTM), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
10/13/17
10/13/17
NO CHANGE
Target $103

Overweight
Morgan Stanley sees Centene pullback on Trump ACA order as buying opportunity
As previously reported, Morgan Stanley analyst Zack Sopcak said he views today's weakness in Centene shares following President Trump's executive order to cut off ACA subsidy payments as a buying opportunity, highlighting three reasons that the move lower is particularly "exaggerated." First, New York AG Eric Schneiderman has said his state and a coalition of other, including California, plan to sue if subsidies were cut off, so the legal fight may delay the impact. Second, Centene has previously said it submitted two bids in most markets; one assuming Cost Sharing Reduction, or CSR, payments, one without. Third, following its pending Fidelis acquisition, he estimates total Centene exposure to exchanges to be about 8%, with roughly 60% of those receiving CSRs. Sopcak reiterate his Overweight rating and $103 price target on Centene, which is down 6% to $88 per share near midday.
CI Cigna
$186.15

-0.81 (-0.43%)

07/12/17
FBCO
07/12/17
INITIATION
Target $195
FBCO
Neutral
Anthem initiated with a Neutral at Credit Suisse
Credit Suisse analyst Scott Fidel started Anthem with a Neutral rating and $195 price target. The company has produced slower earnings growth over the past decade relative to Managed Care peers and its returns on capital are also "sub-par relative to comps," the analyst contends. He believes Anthem is "entering a new chapter" following the failed Cigna (CI) acquisition and "uncertain future" of the Affordable Care Act's exchanges and Medicaid expansion.
10/09/17
JPMS
10/09/17
DOWNGRADE
Target $253
JPMS
Neutral
Humana downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Gary Taylor downgraded Humana (HUM) to Neutral saying insider sales and the August board appointment render it unlikely that acquisition discussions are yet occurring. Further, the Republican's failed attempts to repeal and replace the Affordable Care Act have diminished the probability of the health industry fee repeal, which would have boosted Humana's earnings power by 20%, Taylor tells investors in a research note. The analyst still believes, however, a bid for Humana by Cigna (CI) is plausible in 2018. He keeps a $253 price target on the shares. Humana closed Friday up $1.59 to $246.90.
10/06/17
LEER
10/06/17
NO CHANGE
LEER
Leerink convinced Amazon entering drug distribution within two years
After calls with pharmacy benefit managers and retail pharmacy specialists, Leerink analyst Ana Gupte says she's convinced that Amazon.com (AMZN) "will almost certainly" enter the drug distribution value chain within two years, evolving into a more disruptive offering over time. Amazon's move is most threatening for retail pharmacies Walgreens Boots Alliance (WAB), CVS Health (CVS) and Wal-Mart (WMT), Gupte tells investors in a research note. The analyst calls Amazon both an opportunity and threat for Express Scripts (ESRX) and views UnitedHealth (UNH) and Humana (HUM) as "largely buffered." Gupte's conversations with specialists indicate Amazon is hiring relevant talent and is in active discussions with mid-market pharmacy benefit managers and possibly even with large players such as Prime Therapeutics. It is believed Amazon will start by capturing share in both the cash paying and third party mail order and possibly specialty pharmacy segments, Gupte notes. She expects Anthem (ANTM), Aetna (AET) and Cigna (CI) will likely to contemplate Amazon's entry in their upcoming PBM contract decisions.
HNT Health Net
$0.00

(0.00%)

06/23/17
JEFF
06/23/17
NO CHANGE
JEFF
Jefferies says healthcare rally 'appropriate' after 'toothless' AHCA rewrite
Jefferies analyst David Windley said the rally yesterday in healthcare stocks was appropriate given the "anemic" rewrite of the AHCA healthcare bill by Senate Republicans. The key changes are removal of "pay-for" taxes, a somewhat longer runway for Exchange cost-sharing reduction subsidies, and delayed Medicaid transition to per capita caps, he tells investors. Windley called Cigna (CI) "probably the safest MCO in this noise", adding that Humana (HUM) would benefit most from the proposed removal of the health insurer fee. Other publicly traded healthcare insurers include Aetna (AET), Anthem (ANTM), Centene (CNC), Health Net (HNT), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
11/09/16
BERN
11/09/16
NO CHANGE
BERN
Health insurers to see multiple catalysts from Trump presidency, says Bernstein
Bernstein analyst Lance Wilkes says that "repealing and replacing Obamacare will be Trump's primary focus." The analyst expects health insurers to benefit from from the repeal of ACA taxes and the elimination of requirements to spend a certain percentage of revenue on medical costs. Wilkes expects Anthem (ANTM) and Blue Cross/Blue Shield providers to benefit from the elimination of public exchanges and broad coverage requirements. Other health insurers include Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
HUM Humana
$237.73

-3.71 (-1.54%)

10/09/17
10/09/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Humana (HUM) downgraded to Neutral from Overweight at JPMorgan with analyst Gary Taylor saying insider sales and the August board appointment render it unlikely that acquisition discussions are yet occurring. 2. Viacom (VIAB) downgraded to Sell from Neutral at Citi with analyst Jason Bazinet saying as media and cable companies jockey "for self-preservation," Charter Communications (CHTR) will likely drop, or significantly curtail, distribution of Viacom's content. 3. PTC Therapeutics (PTCT) downgraded to Underweight from Neutral at JPMorgan with analyst Anupam Rama saying the company's valuation remains at near pre-FDA Advisory Committee meetings levels, despite multiple "mixed / inconclusive / negative" updates recently. 4. Medtronic (MDT) downgraded to Market Perform from Outperform at Wells Fargo with analyst Larry Biegelsen saying a "lull" in major product cycles will drive below average organic sales growth over at least the next few quarters. 5. Symantec (SYMC) was downgraded to Underperform from Market Perform at Cowen and to Hold from Buy at Standpoint Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MOH Molina Healthcare
$61.28

-2.14 (-3.37%)

09/21/17
MUFG
09/21/17
INITIATION
Target $70
MUFG
Neutral
Molina Healthcare initiated with a Neutral at MUFG
MUFG analyst Jason Twizell started Molina Healthcare with a Neutral rating and $70 price target.
10/12/17
MSCO
10/12/17
NO CHANGE
Target $68
MSCO
Overweight
Morgan Stanley says Molina CEO pick brings valuable experience
Joseph Zubretsky brings valuable MCO experience to his post as the new CEO of Molina Healthcare (MOH), said Morgan Stanley analyst Zack Sopcak, who added that he would be a buyer on weakness in the shares given that he expects earnings power to be unlocked over the next 12-18 months. During Zubretsky's tenure as CEO of Hanover Insurance (THG), the company's stock rose nearly 20%, while Aetna (AET) shares were up about 4% during his 6 years as CFO there, noted Sopcak, who keeps an Overweight rating on Molina.
UNH UnitedHealth
$192.52

-0.4 (-0.21%)

08/30/17
ADAM
08/30/17
DOWNGRADE
Target $54
ADAM
Hold
The Advisory Board downgraded to Hold from Buy at Canaccord
Canaccord analyst Richard Close downgraded The Advisory Board (ABCO) to Hold from Buy based on the announced transaction to split the company by selling the Healthcare business to UnitedHealth's (UNH) Optum unit and the Education Business to Vista Equity Partners. Close lowered his price target to $54.29 on Advisory Board shares.
WCG WellCare
$168.64

0.33 (0.20%)

09/21/17
MUFG
09/21/17
INITIATION
Target $204
MUFG
Overweight
WellCare initiated with an Overweight at MUFG
MUFG analyst Jason Twizell started WellCare Health Plans with an Overweight rating and $204 price target.
10/09/17
COWN
10/09/17
INITIATION
Target $200
COWN
Outperform
WellCare initiated with an Outperform at Cowen
Cowen analyst Christine Arnold started WellCare Health Plans with an Outperform rating and $200 price target. The turnaround of the company's Medicare business has been "remarkably quick and successful," Arnold tells investors in a research note. The analyst believes organic enrollment growth and capital deployment will drive earnings growth.
CYH Community Health
$5.77

-0.24 (-3.99%)

08/16/17
PIPR
08/16/17
NO CHANGE
PIPR
Piper 'incrementally more bearish' on Hospital sector
Valuations in the Hospital sector have come in, but not enough, Piper Jaffray analyst Sarah James tells investors in a research note. She believes that contradictory to what the hospitals are suggesting, structural headwinds will continue for five-plus years. The analyst believes the group should be trading at a discount. James has an Underweight rating on Community Health Systems (CYH), Overweight ratings on HCA Holdings (HCA) and Universal Health (UHS), and Neutral ratings on LifePoint (LPNT) and Tenet (THC).
08/18/17
DBAB
08/18/17
NO CHANGE
Target $8
DBAB
Hold
Community Health covenant breach a low likelihood, says Deutsche Bank
After analyzing his financial estimates and the company's financial position, Deutsche Bank analyst Chris Rigg believes the likelihood of Community Health Systems breaching its secured debt leverage covenant is low through 2019. The analyst says his analysis follows "market speculation over a near term credit event" at the company. He reduced his 2018 EBITDA estimate by 4% to $1.764B, which he notes is now well below consensus of $1.837B. Rigg keeps a Hold rating on Community Health with an $8 price target.
09/06/17
CANT
09/06/17
NO CHANGE
CANT
Overweight
Irma threat a risk for HCA, public hospital peers, says Cantor
Cantor Fitzgerald analyst Joseph France noted that HCA Holdings (HCA), Community Health (CYH), LifePoint (LPNT), Tenet (THC) and Envision Healthcare (EVHC) all have business in Florida and Texas and are all down today on the potential threat from Hurricane Irma and the impact from Hurricane Harvey last week. HCA reports nearly half of its beds are in Florida and Texas while Envision has said in the past that more than half of its anesthesia business and about half of its legacy ER business is in those two states, noted France, who adds that Community Health, LifePoint and Tenet are less exposed to those states. The analyst keeps an Overweight rating on HCA shares.
08/28/17
JEFF
08/28/17
NO CHANGE
JEFF
Buy
HCA has 11% of its beds in Harvey impacted areas, says Jefferies
Jefferies analyst Brian Tanquilut points out that HCA Holdings (HCA) has 11% of its beds in areas impacted by severe weather from Hurricane Harvey. The analyst expects the hurricane to cause a "notable disruption," specifically for hospitals, physician offices, surgery centers, and labs. Investors are likely to take a long-term view of Hurricane Harvey, however, as it is a one-time issue and thus excluded from operating and financial results, Tanquilut tells investors in a research note. He sees both Tenet (THC) and Community Health (CYH) being minimally impacted from the storm. Envision Healthcare's (EVHC) AmSurg segment has three ambulatory surgery centers in the impacted markets, while Surgery Partners (SGRY) has only one facility in Houston, the analyst adds.
HCA HCA Healthcare
$74.58

0.36 (0.49%)

10/13/17
JEFF
10/13/17
NO CHANGE
Target $92
JEFF
Buy
HCA Healthcare price target lowered to $92 from $100 at Jefferies
Jefferies analyst Brian Tanquilut lowered his price target for HCA Healthcare to $92 after revising his estimates to account for several moving parts, including a retroactive reduction in Texas Medicaid Waiver funding and an "uncertain outlook" for healthcare utilization. His analysis, however, suggests HCA's 2018 EBITDA guidance should bracket consensus. Tanquilut calls hurricanes a Q3 "wildcard," believing weather reduced EBITDA in the quarter by greater than $100M. The analyst keeps a Buy rating on HCA shares.
09/14/17
RBCM
09/14/17
NO CHANGE
RBCM
Tenet unlikely to be acquired, says RBC Capital
After The Wall Street Journal reported that Tenet (THC) hired advisors to purse strategic options, RBC Capital analyst Frank Morgan says that all of Tenet probably won't be acquired, given its "significant" debt levels. He says that the company's ambulatory unit is the most likely part of the company to be sold or spun off. The analyst says that HCA (HCA) could be "interested" in some of Tenet's markets, but he does not believe that it wants to buy all of Tenet's hospitals. The analyst does not expect any deals made by Tenet to cause its share price to increase unless it manages to sell its hospitals for rates above their current market value. Morgan keeps a Sector Perform rating on the stock.
09/14/17
DBAB
09/14/17
NO CHANGE
Target $24
DBAB
Buy
Deutsche sees wide range of potential takeout values for Tenet
Deutsche Bank analyst Chris Rigg believes Tenet Healthcare's (THC) leverage makes for an "extremely wide" range of potential buyout prices. After the Wall Street Journal reported that the company is exploring strategic options including a possible sale, Rigg pegs $21-$41 per share as the potential buyout range. Also difficult is determining who would actually be interested and capable of buying Tenet, Rigg tells investors in a research note. HCA Holdings (HCA) has the financial wherewithal to do a deal, but the companies have significant overlap which could bring antitrust issues, the analyst contends. He sees private equity or an existing private equity-backed hospital chain as making more sense. Rigg has a Buy rating on Tenet with a $24 price target.
LPNT LifePoint
$55.00

0.3 (0.55%)

06/07/17
LEER
06/07/17
UPGRADE
LEER
Outperform
Leerink upgrades hospitals HCA, LifePoint, Tenet to Outperform
Leerink analyst Ana Gupte last night upgraded hospitals HCA Holdings (HCA), LifePoint (LPNT) and Tenet healthcare (THC) to Outperform from Market Perform. She raised her price target for HCA to $100 from $90, for LifePoint to $74 from $73 and maintains a $27 price target for HCA. The targets offer upside of 21%, 20% and 62% respectively. Anthem's (ANTM) announced exit yesterday from the key swing state of Ohio's healthcare exchange could bring further attention to the need for stabilization funding through legislation, Gupte tells investors in a research note. She believes improving policy under the Trump Administration could drive upside to 2018 and 2019 consensus estimates. Further, the analyst thinks medium term downside risk from Republican's repeal and replace healthcare bill is likely better than feared as publicly traded hospitals are "heavily weighted to non-expansion states," which lessons the impact of Medicaid expansion funding cuts.
06/23/17
LEER
06/23/17
NO CHANGE
LEER
Outperform
Draft version of Senate healthcare bill better than expected, says Leerink
Leerink analyst Ana Gupte said she views the draft version of the Senate healthcare bill as better than expected, stating that stabilization of the Exchanges and risk stabilization is a direct positive for health insurers and indirect positive for facility operators. The Senate bill maintains the House bill's plan to repeal all "ObamaCare" industry fees and taxes, which is a positive for Managed Care and Medical Technology players, Gupte adds. She keeps Outperform ratings on Anthem (ANTM), UnitedHealth (UNH), Cigna (CI), Humana (HUM), WellCare (WCG), Molina Healthcare (MOH) and acute care hospital operators HCA Holdings (HCA), Tenet (THC) and LifePoint (LPNT).
THC Tenet
$13.15

-0.71 (-5.12%)

09/14/17
KEYB
09/14/17
NO CHANGE
KEYB
Tenet unlikely to find buyer for whole company, says KeyBanc
KeyBanc analyst Jason Gurda notes that Bloomberg is reporting that Tenet has hired advisers to explore strategic alternatives, including a potential sale. The analyst believes it is unlikely it will find a buyer for the whole company due to its high level of debt and the likely lack of interest from potential strategic buyers. However, Gurda does believe that Tenet could expand its effort to divest individual hospitals and/or its Conifer subsidiary at multiples that would be accretive to where the shares are currently trading and would accelerate de-leveraging. But it is not clear at the moment how far management is willing to go in breaking up the business, he adds.
09/14/17
RHCO
09/14/17
NO CHANGE
RHCO
'Potential public suitors' for Tenet 'limited,' says SunTrust
SunTrust analyst David MacDonald says that "potential public suitors" for Tenet are "limited," while its free cash flow "remains sluggish." However, the analyst says that the company's assets are "intriguing," as its non-hospital assets are being undervalued by the market. He keeps a $16 price target and a Hold rating on the shares.
UHS Universal Health
$105.55

-0.37 (-0.35%)

10/11/17
SPHN
10/11/17
INITIATION
Target $120
SPHN
Equal Weight
Universal Health initiated with an Equal Weight at Stephens
Stephens analyst Dana Hambly started Universal Health with an Equal Weight rating and $120 price target, noting that the company is the leader in the behavioral health industry, but that behavioral health volume growth has been below expectations and acute-care volume growth has slowed. Hambly said he would become more constructive on the stock should behavioral organic growth pick up.
06/06/17
MSCO
06/06/17
INITIATION
Target $124
MSCO
Equal Weight
Universal Health initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Zack Sopcak initiated Universal Health with an Equal Weight rating and $124 price target, citing volume and price pressures on the hospital industry expected over the next several years.
05/31/17
PIPR
05/31/17
NO CHANGE
PIPR
Piper raises 'early caution flag' for Q2 hospital earnings
Following her firm's May outpatient survey, Piper Jaffray analyst Sarah James is putting up an "early caution flag" for Q2 hospital earnings. The May outpatient survey indicates April was the peak, declining in May, with indications that June could be below April as well, James tells investors in a research note. After four months of increases, the outpatient survey declined 50 basis points from the April peak to 2.5% year-over-year same-hospital admissions in May, the analyst adds. She views the decline as concerning amid "tenuous" investor sentiment and "optimistic" Q2 expectations. Hospitals that Piper covers include Community Health (CYH), HCA Holdings (HCA), LifePoint (LPNT), Tenet (THC) and Universal Health (UHS).

TODAY'S FREE FLY STORIES

VNOM

Viper Energy

$38.34

0.91 (2.43%)

21:49
08/16/18
08/16
21:49
08/16/18
21:49
Upgrade
Viper Energy rating change  »

Viper Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LIFE

aTyr Pharma

$0.63

(0.00%)

21:45
08/16/18
08/16
21:45
08/16/18
21:45
Upgrade
aTyr Pharma rating change  »

aTyr Pharma upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLT

Hilton

$77.25

1.04 (1.36%)

21:44
08/16/18
08/16
21:44
08/16/18
21:44
Downgrade
Hilton rating change at Bernstein »

Hilton downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$335.46

-3.2 (-0.94%)

20:50
08/16/18
08/16
20:50
08/16/18
20:50
Periodicals
Tesla Fremont facility workers left 3.5 hours early on Wednesday, BI reports »

Workers at Tesla's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

SPX

S&P 500

$0.00

(0.00%)

, FXI

iShares China Large-Cap ETF

$41.00

0.41 (1.01%)

20:43
08/16/18
08/16
20:43
08/16/18
20:43
Periodicals
Pentagon: China expanded bomber training to overwater areas, Reuters says »

In its annual report, the…

SPX

S&P 500

$0.00

(0.00%)

FXI

iShares China Large-Cap ETF

$41.00

0.41 (1.01%)

BA

Boeing

$345.89

14.16 (4.27%)

HII

Huntington Ingalls

$244.50

3.68 (1.53%)

LMT

Lockheed Martin

$325.86

8.31 (2.62%)

NOC

Northrop Grumman

$291.97

0.45 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$137.38

1.68 (1.24%)

20:25
08/16/18
08/16
20:25
08/16/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

MCD

McDonald's

$161.71

1.82 (1.14%)

19:48
08/16/18
08/16
19:48
08/16/18
19:48
Hot Stocks
FDA updates on investigation of McDonald's salad-related Cyclospora illnesses »

As of August 16, 2018, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

TRP

TransCanada

$43.82

0.05 (0.11%)

19:40
08/16/18
08/16
19:40
08/16/18
19:40
Hot Stocks
TransCanada does not endorse mini-tender by TRC Capital »

TransCanada has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMS

Scientific Games

$30.70

1.4 (4.78%)

, INSE

Inspired Entertainment

$7.15

(0.00%)

19:21
08/16/18
08/16
19:21
08/16/18
19:21
Hot Stocks
Scientific Games and Pennsylvania Lottery launch virtual sports »

Scientific Games (SGMS)…

SGMS

Scientific Games

$30.70

1.4 (4.78%)

INSE

Inspired Entertainment

$7.15

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRYS

Krystal Biotech

$15.63

0.23 (1.49%)

19:19
08/16/18
08/16
19:19
08/16/18
19:19
Syndicate
Krystal Biotech announces $10M private placement with Frazier Healthcare »

Krystal Biotech announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

LBC

Luther Burbank

$10.90

-0.09 (-0.82%)

19:08
08/16/18
08/16
19:08
08/16/18
19:08
Hot Stocks
Luther Burbank authorizes stock buyback of up to $15M »

Luther Burbank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

ARAY

Accuray

$3.50

0.05 (1.45%)

, JWN

Nordstrom

$52.30

0.44 (0.85%)

19:00
08/16/18
08/16
19:00
08/16/18
19:00
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

ARAY

Accuray

$3.50

0.05 (1.45%)

JWN

Nordstrom

$52.30

0.44 (0.85%)

CRMT

America's Car-Mart

$66.95

1.85 (2.84%)

ATAI

ATA Inc.

$6.87

0.13 (1.93%)

CORT

Corcept Therapeutics

$12.51

0.01 (0.08%)

VJET

voxeljet

$3.51

0.11 (3.24%)

VNET

21Vianet

$9.45

0.44 (4.88%)

ATGE

Adtalem Global Education

$55.70

-0.3 (-0.54%)

NVDA

Nvidia

$257.57

-1.41 (-0.54%)

AMAT

Applied Materials

$47.42

-0.07 (-0.15%)

MU

Micron

$47.10

-0.38 (-0.80%)

LRCX

Lam Research

$174.22

1.42 (0.82%)

ZOES

Zoe's Kitchen

$9.52

0.04 (0.42%)

VCEL

Vericel

$11.50

-0.075 (-0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 16

    Aug

  • 16

    Aug

  • 16

    Aug

  • 16

    Aug

  • 16

    Aug

  • 17

    Aug

  • 17

    Aug

  • 22

    Aug

  • 04

    Sep

  • 05

    Sep

  • 12

    Sep

  • 27

    Sep

  • 06

    Nov

NVEE

NV5 Global

$84.05

1.55 (1.88%)

18:55
08/16/18
08/16
18:55
08/16/18
18:55
Hot Stocks
NV5 Global CEO sells 190,500 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

  • 20

    Sep

  • 21

    Sep

GOOG

Alphabet

$1,206.00

-7.65 (-0.63%)

, GOOGL

Alphabet Class A

$1,223.55

-8.75 (-0.71%)

18:54
08/16/18
08/16
18:54
08/16/18
18:54
Periodicals
Google submits plans for Moffett Park development, SVBJ reports »

Alphabet's Google…

GOOG

Alphabet

$1,206.00

-7.65 (-0.63%)

GOOGL

Alphabet Class A

$1,223.55

-8.75 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

WMT

Walmart

$98.63

8.39 (9.30%)

18:38
08/16/18
08/16
18:38
08/16/18
18:38
Recommendations
Walmart analyst commentary at Baird »

Walmart price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

AVEO

Aveo Pharmaceuticals

$2.26

0.085 (3.91%)

18:35
08/16/18
08/16
18:35
08/16/18
18:35
Syndicate
Aveo Pharmaceuticals files to sell common stock, no amount given »

Piper Jaffray & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

ZN

Zion Oil & Gas

$2.53

0.16 (6.75%)

18:15
08/16/18
08/16
18:15
08/16/18
18:15
Hot Stocks
Zion Oil & Gas confirms active petroleum system in Megiddo-Jezreel #1 well »

Zion Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRS

Amyris

$7.49

0.07 (0.94%)

18:14
08/16/18
08/16
18:14
08/16/18
18:14
Syndicate
Amyris files to sell 7.4M shares of common stock for holders »

In connection with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CORT

Corcept Therapeutics

$12.51

0.01 (0.08%)

18:07
08/16/18
08/16
18:07
08/16/18
18:07
Hot Stocks
Corcept Therapeutics board member Leonard Baker buys $2.2M in common stock »

Corcept Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 12

    Sep

ETSY

Etsy

$45.68

0.83 (1.85%)

17:44
08/16/18
08/16
17:44
08/16/18
17:44
Hot Stocks
Etsy chairman Frederick Wilson sells $1M in common stock »

Etsy chairman Frederick…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

NVDA

Nvidia

$257.57

-1.41 (-0.54%)

, TCEHY

Tencent

$0.00

(0.00%)

17:37
08/16/18
08/16
17:37
08/16/18
17:37
Hot Stocks
Nvidia says 'Fortnite,' 'PUBG' have strengthened video game market »

Nvidia (NVDA) says gaming…

NVDA

Nvidia

$257.57

-1.41 (-0.54%)

TCEHY

Tencent

$0.00

(0.00%)

DIS

Disney

$112.49

-0.42 (-0.37%)

MSFT

Microsoft

$107.65

-0.02 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 04

    Sep

  • 12

    Sep

RCUS

Arcus Biosciences

$12.89

-0.05 (-0.39%)

17:37
08/16/18
08/16
17:37
08/16/18
17:37
Hot Stocks
Arcus Biosciences CEO Terry Rosen buys over 28K shares of company stock »

Arcus Biosciences CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

GLD

SPDR Gold Trust

$111.11

-0.1 (-0.09%)

17:30
08/16/18
08/16
17:30
08/16/18
17:30
Hot Stocks
SPDR Gold Trust holdings fall to 773.41MT from 774.59MT »

This is the 4th…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSTR

L.B. Foster

$23.05

-0.1 (-0.43%)

17:28
08/16/18
08/16
17:28
08/16/18
17:28
Hot Stocks
Breaking Hot Stocks news story on L.B. Foster »

Legion Partners lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HALO

Halozyme

$17.10

-0.1 (-0.58%)

17:25
08/16/18
08/16
17:25
08/16/18
17:25
Hot Stocks
Halozyme director and beneficial owner Randal Kirk sells over 490K shares »

Halozyme director and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.